Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 3, 2022
- Accepted July 3, 2023
- Published online July 14, 2023.
Article Versions
- You are currently viewing a previous version of this article (July 14, 2023 - 05:53).
- View the most recent version of this article
Copyright & Usage
Copyright © 2023, Parenteral Drug Association
Author Information
- Joanny Salvas1 (joanny.salvas{at}pfizer.com),
- Petra Merker2 (petra.merker{at}bayer.com),
- Mike Dingle3 (michael.dingle{at}tsi.com),
- Cedric Joossen4 (cjoossen{at}its.jnj.com),
- Chris Knutsen5 (chris.knutsen{at}bms.com),
- David Govezensky6 (david.govezensky{at}btgil.com),
- Jim Cannon7 (jim.cannon{at}mt.com),
- Philip Villari8 (philip_villari{at}merck.com),
- Anthony M Cundell9 (tonycundell{at}gmail.com),
- Victoria Navarro10 (victoria.navarrolahoz{at}pfizer.com),
- Margit Franz-Riethdorf11,13 (margit.franz-riethdorf{at}biophorum.com) and
- Allison Scott12 (awilhelmscott{at}gmail.com)
- 1 Pfizer, Kirkland, QC, Canada / BioPhorum;
- 2 Bayer AG, Mullerstr. 178, D-13353 Berlin, Germany / BioPhorum;
- 3 TSI Incorporated, 500 Cardigan Road, Shoreview, MN 55126 USA / PEMM;
- 4 Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium / OWBA;
- 5 Bristol-Myers Squibb, New Brunswick, NJ, USA / BioPhorum;
- 6 Bio-Technology General (Israel) Ltd., POB 571, Be'er Tuvia Industrial Zone, Kiryat Malachi 8310402, Israel / BioPhorum;
- 7 Mettler-Toledo Thornton, Inc., 900 Middlesex Turnpike, Building 8, Billerica, MA 01821 / PEMM;
- 8 Merck & Co., Inc., Kenilworth, NJ, USA / BioPhorum / PEMM;
- 9 Microbiological Consulting, LLC., Rye, NY 10580 USA / PEMM;
- 10 Pfizer, S. S. de los Reyes, Madrid, Spain / BioPhorum;
- 11 BioPhorum Operations Group Limited, 5 Westbrook Court, Sharrowvale Road, Sheffield, S11 8YZ, UK;
- 12 Azbil North America Research and Development: BioVigilant, 2005 W. Ruthrauff Rd. #151, Tucson, AZ 85705 USA / PEMM
- ↵* Corresponding author; email: margit.franz-riethdorf{at}biophorum.com
